YOD1 serves as a potential prognostic biomarker for pancreatic cancer

Table 1 Differences in the transcription level of the OTUD family in pancreatic cancer and normal pancreatic tissues (ONCOMINE: gene rank < 10%)

Gene	Pathology	Fold change	P-value	t-Test	References
OTUD1	PDAC	1.786 –1.347	8.90E-4 0.029	3.313 –1.938	Ishikawa pancreas [24] Ishikawa pancreas [24]
YOD1*	PC	2.386	4.43E-8	6.695	Pei pancreas [36]
OTUD3	PDAC	1.438	0.041	1.836	Grutzmann pancreas [11]
OTUD4	\	\	\	\	\
OTUD5	PDAC	1.415	2.29E-4	4.783	Buchholz pancreas [8]
OTUD6A	\	\	\	\	\
OTUD6B	PAAD	1.079	6.18E-5	4.386	TCGA pancreas [32]
ALG13	PDAC	− 1.911	0.031	− 1.911	Ishikawa pancreas [24]

PDAC pancreatic ductal adenocarcinoma, PC pancreatic cancer, PAAD pancreatic adenocarcinoma

ISSN: 1475-2867